How to Group Multiple Models for Overseas Registration of Laboratory Equipment?

Key Summary

For overseas registration of laboratory equipment, multiple models can be submitted as a group using the "primary model representative + difference assessment" method to reduce duplicate testing and documentation costs. Companies should first confirm whether the target country regulates the product as a medical device and its risk class, then select the appropriate registration pathway. It is recommended to group series products with the same core technology, identical intended use, and differences that do not affect safety or effectiveness into one registration unit. Submit the primary model's technical documentation, performance validation, and risk management report, and list differences model-by-model.

Prepare quality system certificates such as ISO 13485, labeling and instructions for use compliant with local regulations, and local agent or authorized representative documents. Also plan for post-market maintenance and change control. For GHWP member countries, leveraging international harmonized documents can reduce costs, but always verify each country's specific requirements. Common risks include misjudging the regulatory classification, overlooking local technical standards, and insufficient evidence leading to requests for amendments. Companies should prioritize organizing existing NMPA, CE, FDA, and other data, assess reusability, and perform localization conversion according to target country requirements to avoid redundant testing.

It is advisable to complete full submission in one country first, then replicate it in other markets. Using a "master file + difference modules" strategy significantly improves efficiency for multi-country registration.

Applicable Scenarios and Core Issues

Laboratory equipment overseas registration often involves a series with multiple models—different capacities, temperature ranges, voltage versions, accessory configurations, etc. If each model is submitted independently, registration fees and timelines multiply, and technical documentation may be duplicated or trigger regulatory queries.

This article is intended for manufacturers preparing to enter GHWP member countries, Southeast Asia, the Middle East, Latin America, and other markets. It explains under which conditions multiple models can be grouped as one registration unit and the requirements to satisfy.

The core question can be summarized as: how to define the boundary of a "registration unit," which model serves as the primary model, how to prove that non-primary models are substantially equivalent to the primary model in safety and effectiveness, and how to prepare a technical documentation set usable for multi-country submissions.

Registration Decision Logic

First step: Determine whether the target country regulates the laboratory equipment as a medical device. Definitions vary by country; for example, some IVD instruments may be medical devices, while ordinary laboratory centrifuges may not. Review local regulations or consult a local agent.

Second step: Determine the risk class and registration pathway. Based on intended use, human contact, diagnostic information, etc., products may be low or medium-high risk, corresponding to different processes. ASEAN countries often reference risk classification and approval levels.

Third step: Confirm the applicant entity. Some countries require a local registrant; manufacturers must appoint a local agent or authorized representative with legal responsibilities. For grouped submissions, the local agent must cover all models in the registration unit.

Fourth step: Assess the reusability of existing documentation. If you already have NMPA registration, CE certificates, FDA 510(k), or ISO 13485, identify which technical reports, test reports, and QMS evidence can be used for overseas registration and which need supplements or updates.

Fifth step: Establish the grouping strategy. In principle, products in the same registration unit must have the same intended use, similar design principles, and key components, and differences must not introduce new safety risks. Select a typical model as the primary model, submit complete technical documentation, and link other models via a difference table and supporting evidence.

For GHWP member countries, reference international harmonized documents such as IMDRF's registration dossier specifications, but verify the national list because some countries have additional requirements.

Documentation and Evidence

Technical documentation for a grouped submission should center on the primary model, covering product description, intended use, design verification, materials, manufacturing process, risk management, and performance testing.

Key evidence to submit includes:

• Product technical parameter table
• Risk assessment report (ISO 14971)
• Critical components list
• EMC and electrical safety test reports (IEC 61010 series or other applicable standards)
• Performance validation reports
• Stability or reliability data
• Label and instructions for use samples

If the product has measurement or diagnostic functions, provide metrological traceability or clinical evidence, or at least a scientifically sound performance evaluation basis.

Quality management system certification is mandatory, typically ISO 13485 or equivalent GMP proof. Some countries accept MDSAP as supplementary evidence, but it does not replace local system audits.

Localization conversion includes translating labeling and IFU into the official language, adapting to local units, plugs, voltage, and climate conditions, and updating warnings and symbols per local regulations.

Provide a model-to-model difference matrix clearly listing specification, function, and accessory variations, and explain whether differences affect basic safety and essential performance.

Common Mistakes

• Grouping products with different intended uses or significant principle differences into one registration unit, leading to amendments or rejection.
• Submitting only the primary model's documentation without a difference analysis for other models, especially lacking substantial equivalence argumentation.
• Ignoring special classification rules for laboratory equipment in the target country and incorrectly applying as a general electrical appliance.
• Directly using domestic or CE reports without verifying whether the target country accepts the standard version or test laboratory qualifications.
• Failing to clarify responsibilities with the local agent before submission, resulting in incomplete authorization documents or authorization covering only the primary model.
• Missing post-market change control—when a model design changes, not assessing the impact on the entire registration unit.
• Labels and IFU are literal translations without adjusting warnings, contraindicated populations, etc., per local culture and regulations.

Company Preparation Checklist

• Build a product series matrix listing all models, specification differences, target markets, and available technical data.
• Confirm the target country's registration regulations, risk classification, and registration unit requirements.
• Select a primary model and prepare its complete technical documentation and test reports.
• Create a difference comparison table for each model versus the primary model, and add verification or evaluation records for differences.
• Organize existing NMPA, CE, FDA, ISO 13485, MDSAP evidence; mark items reusable and items requiring re-acquisition.
• Sign an authorization agreement with the local agent covering all models intended for registration and future change management processes.
• Initiate label and IFU localization early and have it reviewed by local regulatory personnel.
• Establish validity monitoring and renewal plans for each registration certificate to avoid market access interruption.

AIMEILI Regulatory Interpretation and Business Impact

Interpretation: The most common misjudgment is treating "similar appearance" as a reason for grouping into one registration unit. Regulators focus on intended use, technical principles, and risk differences. Conduct an internal gap analysis before grouping, and if necessary, engage an external regulatory consultant to review.

The most valuable early step is not translating documents immediately but confirming the target country's regulatory framework and product classification. If the direction is wrong, all subsequent work is compromised.

Reusable documentation typically includes QMS certificates, general performance tests, EMC and electrical safety reports. Localization is required for IFU, labels, risk management considerations aligned with local standards, and certain country-specific test items.

A local agent is not merely a document transmitter. Certificate control, changes, and renewals all depend on the agent's communication capability with the regulatory authority. Clearly define service scope, response time, and change notification obligations in the cooperation agreement.

Business Impact: For multi-country registration, treat the primary model's technical documentation as a "master file" and generate country-specific submission versions through difference modules. This significantly reduces document duplication and amendment risks. We recommend completing a full submission in one country first, resolving any deficiencies, then replicating to other countries instead of starting multiple high-risk submissions simultaneously. This approach shortens time-to-market, lowers registration costs, and improves success rates across jurisdictions.

Frequently Asked Questions

Q: Must all models appear on the certificate?

Yes, typically. The registration certificate lists all approved model names and specifications. To facilitate coverage, consider including models that may be extended in the future, but ensure they fall within the same registration unit technically and avoid listing empty models not intended for production, as this creates maintenance burdens.

Q: If the primary model is not sold in a certain country, can it still be used as a representative?

Yes, provided the primary model's technical documentation is complete and you can explain to the local agent or regulator the relationship between the primary model and the models actually sold. However, some countries may require the primary model to have legal market status or local test reports. Therefore, communicate with the target country's regulator or agent before selecting the primary model.

Q: How to add a new model after multi-model registration?

This falls under change registration. Evaluate whether the new model fits the existing registration unit. If it does, apply for an additional model with difference analysis, performance validation, and updated labeling/IFU.

Q: Can grouping strategies be identical across different countries?

No. Registration unit boundaries and review requirements differ by country; for example, some countries do not accept grouping across product categories. Always base decisions on the target country's regulations and adapt international common documents accordingly.